$0.01
(Market cap
$35 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-29 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
29.94
-
EV/EBITDA
0.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
73,975,200
7 Years Aggregate
CFO
$-664.42 Mln
EBITDA
$-813.60 Mln
Net Profit
$-841.67 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sio Gene Therapies (SIOX)
| 29.2 | 24.2 | 21.0 | 4.8 | -45.8 | -46.4 | -- |
|
BSE Sensex*
| -10.2 | -0.9 | -7.6 | -7.0 | 7.1 | 8.5 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Sio Gene Therapies (SIOX)
| -14.9 | -66.3 | -53.6 | -45.7 | -35.7 | -80.9 | -57.6 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sio Gene Therapies (SIOX)
|
0.5 | 35.4 | 0.0 | -28.2 | -- | -58.1 | -- | 0.8 |
| 16.7 | 380.1 | 21.8 | 69.9 | -467.1 | 76.8 | -- | 4.7 |
Shareholding Pattern
View DetailsAbout Sio Gene Therapies (SIOX)
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and... commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York. Read more
-
CEO, CFO, Chief Accounting Officer, General Counsel & Director
Mr. David W. Nassif J.D.
-
CEO, CFO, Chief Accounting Officer, General Counsel & Director
Mr. David W. Nassif J.D.
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Sio Gene Therapies (SIOX)
What is the current share price of Sio Gene Therapies Inc (SIOX) Today?
The share price of Sio Gene Therapies Inc (SIOX) is $0.48 (NASDAQ) as of 07-Feb-2024 15:59 EDT. Sio Gene Therapies Inc (SIOX) has given a return of -45.85% in the last 3 years.
What is the current PB & PE ratio of Sio Gene Therapies Inc (SIOX)?
Since, TTM earnings of Sio Gene Therapies Inc (SIOX) is negative, P/E ratio is not available.
The P/B ratio of Sio Gene Therapies Inc (SIOX) is 0.78 times as on 07-Feb-2024, a 87 discount to its peers’ median range of 6.06 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.68
|
0.81
|
|
2021
|
-4.19
|
1.10
|
|
2020
|
-0.84
|
0.99
|
|
2019
|
-0.16
|
0.38
|
|
2018
|
-0.08
|
0.24
|
What is the 52 Week High and Low of Sio Gene Therapies Inc (SIOX)?
The 52-week high and low of Sio Gene Therapies Inc (SIOX) are Rs -- and Rs -- as of 26-May-2026.
What is the market cap of Sio Gene Therapies Inc (SIOX)?
Sio Gene Therapies Inc (SIOX) has a market capitalisation of $ 35 Mln as on 07-Feb-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in Sio Gene Therapies Inc (SIOX)?
Before investing in Sio Gene Therapies Inc (SIOX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.